110 related articles for article (PubMed ID: 7291202)
1. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
Magon A; Leipzig RM; Bloom K; Brewer GJ
Prog Clin Biol Res; 1981; 55():709-24. PubMed ID: 7291202
[TBL] [Abstract][Full Text] [Related]
2. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
Magon AM; Leipzig RM; Zannoni VG; Brewer GJ
J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
[TBL] [Abstract][Full Text] [Related]
3. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
Bashan N; Peleg N; Moses SW
Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
[No Abstract] [Full Text] [Related]
4. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Grossman S; Budinsky R; Jollow D
J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
[TBL] [Abstract][Full Text] [Related]
5. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Ali NA; al-Naama LM; Khalid LO
East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
[TBL] [Abstract][Full Text] [Related]
6. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells.
Scott GL; Rasbridge MR
Br J Haematol; 1973 Mar; 24(3):307-17. PubMed ID: 4713632
[No Abstract] [Full Text] [Related]
7. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
Beutler E; Duparc S;
Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
[TBL] [Abstract][Full Text] [Related]
8. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS.
Glader BE; Conrad ME
J Lab Clin Med; 1973 Feb; 81(2):267-72. PubMed ID: 4683425
[No Abstract] [Full Text] [Related]
9. G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
Moore GS; Calabrese EJ
J Environ Pathol Toxicol; 1980 Sep; 4(2-3):271-9. PubMed ID: 7462905
[TBL] [Abstract][Full Text] [Related]
10. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
Dziewulska KH; Reisz JA; Hay AM; D'Alessandro A; Zimring JC
J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
[TBL] [Abstract][Full Text] [Related]
11. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients].
Grieger M; Schippel W; Siems W; Leppin K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):704-15. PubMed ID: 6198254
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced glucose-6-phosphate dehydrogenase deficiency-related hemolysis risk assessment.
Yang Y; Li Z; Nan P; Zhang X
Comput Biol Chem; 2011 Jun; 35(3):189-92. PubMed ID: 21704265
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced hemolysis: biochemical considerations.
Shahidi NT
Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
[No Abstract] [Full Text] [Related]
14. DNA damage and apoptosis in mononuclear cells from glucose-6-phosphate dehydrogenase-deficient patients (G6PD Aachen variant) after UV irradiation.
Efferth T; Fabry U; Osieka R
J Leukoc Biol; 2001 Mar; 69(3):340-2. PubMed ID: 11261779
[TBL] [Abstract][Full Text] [Related]
15. [Hemolytic effect of niridazole in G6PD deficiency].
Coulaud JP; Payet M; Kaplan JC; Ba M
Nouv Presse Med; 1976 Nov; 5(40):2720-1. PubMed ID: 1005089
[No Abstract] [Full Text] [Related]
16. Absence of hemolytic effects of L-DOPA on transfused G6PD-deficient erythrocytes.
Gaetani G; Salvidio E; Pannacciulli I; Ajmar F; Paravidino G
Experientia; 1970; 26(7):785-6. PubMed ID: 5431157
[No Abstract] [Full Text] [Related]
17. Microsomal incubation test of potentially hemolytic drugs for glucose-6-phosphate dehydrogenase deficiency.
Bloom KE; Brewer GJ; Magon AM; Wetterstroem N
Clin Pharmacol Ther; 1983 Apr; 33(4):403-9. PubMed ID: 6572582
[TBL] [Abstract][Full Text] [Related]
18. Nature of hemolytic crises and the fate of G6PD deficient, drug-damaged erythrocytes in Sardinians.
Salvidio E; Pannacciulli I; Tizianello A; Ajmar F
N Engl J Med; 1967 Jun; 276(24):1339-44. PubMed ID: 6024564
[No Abstract] [Full Text] [Related]
19. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Irshaid Y; Adedoyin A; Lotze M; Branch RA
Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
[TBL] [Abstract][Full Text] [Related]
20. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
